Rivaroxaban, which has been approved by the FDA to treat deep vein thrombosis (DVT) or pulmonary embolism (PE) and to reduce the risk of recurrent DVT and PE following initial treatment, also appears to be resource friendly, according to two abstracts presented at the 2012 American Society of Hematology’s (ASH) annual meeting in Atlanta.

Atrial fibrillation (AF) places a heavy financial burden on the U.S. healthcare system, but cardiologists may help to chip away at these costs.

The Supreme Court’s decision to uphold most elements of the Patient Protection and Affordable Care Act ensured that major structural changes in healthcare will continue to rapidly evolve. 

Ty Cobb Regional Medical Center in Lavonia, Ga., applied a creative business model to build when others were shuttering their doors.

Does pharma spending on direct-to-consumer advertising of prescription drugs benefit patients? Yes, according to an analysis of statins that found increased expenditure in advertising helped to bring undiagnosed consumers into physician offices.

Earlier this month, a hospital group in Florida agreed to pay the federal government more than $10 million to settle a lawsuit over billing for interventional cardiac and vascular procedures. I doubt it will be the last we’ll see of cases involving reimbursement for inpatient services.